Randox at AACC 2018 - Booth #3624

Location : McCormick Place, Chicago, Illinois
  Date : July 31st - August 2nd 2018

Renal Panels

Recently, our dedicated scientists have developed two new renal tests, utilising our proprietary Biochip Array Technology (BAT) that simultaneously and quantitatively detects multiple early biomarkers associated with kidney damage and injury to allow earlier intervention for treatment, as well as the prevention of further kidney damage and injury. These are known as the Acute Kidney Injury Array and the Chronic Kidney Disease Array.


Acute Kidney

  • AKI 5-plex biomarker array; NGAL, Cystatin C, Clusterin, KIM-1 and Osteopontin
  • Simultaneous and quantitative detection of kidney injury from one sample
  • Novel biomarker indicators for early acute kidney injury
  • Utilised on the revolutionary multiplex Evidence Investigator


Chronic Kidney Disease

  • Chronic Kidney Disease 4-plex biomarker array; CRP, C3a des Arg, NGAL and Cystatin C
  • Chronic Kidney Disease 7-plex biomarker array; MIP1alpha, IL-8, sTNFR1, sTNFR2, EGF, D-dimer and FABP1
  • Determines chronic kidney disease stages leading to more effective treatment
  • Utilized on our patented revolutionary Evidence platforms